Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Avivagen Inc > 28,000$ SALES IN A YEAR exemplary succes-WOW-
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by DrJayseron Feb 15, 2021 8:30am
131 Views
Post# 32567433

RE:RE:RE:28,000$ SALES IN A YEAR exemplary succes-WOW-

RE:RE:RE:28,000$ SALES IN A YEAR exemplary succes-WOW-Truly sorry to hurt your feelings. Bashing?!? Im just reading the filings and telling it as it is. 

15 years as a public entity , how many PR issued?

Results.....1M$ in sales per annum , 35M$ accu. losses.

If the Dog whisperer couldn't sell their Dog treats....and CSA has not been able to order 1 kg of their supposedly disruptive OxC-B, I believe it tells the real story.

Again Truly sorry :-)

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities